Diagnosing and Treating Neurosyphilis
Diagnostic Approach
- The Centers for Disease Control and Prevention recommends CSF examination in patients with neurologic or ocular symptoms/signs, active tertiary syphilis, treatment failure for non-neurologic syphilis, or HIV-infected patients with late-latent syphilis or syphilis of unknown duration 1, 2, 4
- CSF examination is the cornerstone of neurosyphilis diagnosis, with findings suggestive of neurosyphilis including reactive CSF-VDRL, CSF WBC >10 cells/µL, and normal or mildly elevated protein concentration 1, 4
- A reactive CSF-VDRL plus CSF WBC >10 cells/µL strongly supports the diagnosis of neurosyphilis 1, 3
- The Centers for Disease Control and Prevention notes that CSF treponemal tests are sensitive but not specific, and a nonreactive test excludes neurosyphilis, but a reactive test does not confirm it 1, 3
Treatment Recommendations
- The Centers for Disease Control and Prevention recommends penicillin G crystalline aqueous, 18-24 million units IV daily, administered as 3-4 million units every 4 hours or by continuous infusion for 10-14 days as the first-line treatment for neurosyphilis 4, 5
- For penicillin-allergic patients, desensitization is recommended as penicillin remains the only proven effective treatment 4, 5
Follow-Up and Monitoring
- The Centers for Disease Control and Prevention recommends CSF examination should be repeated at 6-month intervals until the cell count normalizes, and serologic tests should be repeated at 3, 6, 12, and 24 months to evaluate treatment response 3, 5, 6
- A four-fold decline in titer indicates adequate response to treatment 5, 6
Clinical Pitfalls and Caveats
- The Centers for Disease Control and Prevention notes that false-negative serologic tests can occur in HIV-infected patients with documented T. pallidum infection, and if clinical suspicion is high despite negative serology, other diagnostic procedures should be pursued 1, 7
- Jarisch-Herxheimer reaction may occur within 24 hours of treatment initiation 5, 6